All In Biotech

Free tool

FAERS Monitor: Pitocin

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 018261 or its brand name (Pitocin, Oxytocin). Reports on generic versions are filed under their own applications.

Reports

3,047

Serious

2,695

88% of reports

Hospitalization

914

Death reported

155

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • foetal exposure during pregnancy456
  • maternal exposure during pregnancy441
  • drug ineffective402
  • exposure during pregnancy366
  • premature baby209
  • hypotension196
  • off label use191
  • premature delivery163
  • postpartum haemorrhage155
  • drug exposure during pregnancy143
  • maternal exposure during delivery137
  • caesarean section105
  • low birth weight baby104
  • nausea101
  • dyspnoea95

Reports by year received

View as table
YearReports
200440
200533
200661
200744
200871
200956
201087
201175
201279
2013104
2014128
2015128
2016196
2017149
2018182
2019144
2020213
2021200
2022237
2023298
2024203
2025173
2026144

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,051,112 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
maternal exposure during deliverySignal1371108.3928.7129,666
postpartum haemorrhageSignal155897.6762.2122,075
low birth weight babySignal10491.575.79,105
premature deliverySignal16371.461.411,133
caesarean sectionSignal10562.852.06,268
premature babySignal20948.342.39,573
exposure during pregnancySignal36640.937.114,159
foetal exposure during pregnancySignal45638.935.816,787
maternal exposure during pregnancySignal44134.331.514,223
drug exposure during pregnancySignal14329.124.83,849
hypotensionSignal1966.85.9963
drug ineffectiveSignal4022.11.9248
off label use1911.51.333
dyspnoea951.21.02
nausea1010.90.72

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.